Diabetes drug shows potential in treating Parkinson ’s disease

A medicine for type 2 diabetes may slow the progression of the symptoms of Parkinson’s disease, research has suggested. Investigators evaluating the glucagon-like peptide 1 receptor agonist (GLP-1 RA) lixisenatide reported less progression of motor disability over a 12-month period in patients taking the drug compared with placebo. But writing in the New England Journal of Medicine, they... Read moreThe post Diabetes drug shows potential in treating Parkinson’s disease appeared first on Nursing in Practice.
Source: Nursing in Practice - Category: Nursing Authors: Tags: Clinical Diabetes Latest news Source Type: news